Reveragen Biopharma, Inc.

Springfield, VA

UEI
NQA4J3L3E1Z4
CAGE
59ZX0
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
6347 Willowfield Way, Springfield, VA 22150, USA
Website
reveragen.com
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Vamorolone trial in becker muscular dystrophy R01FD007284 FDA Office of Acquisition and Grant Services $3,002,557
Building an evidentiary case for circulating ghbp as a biomarker for drug-associated stunting of growth R41HD094622 National Institute of Child Health and Human Development (NIH) $224,998
Definition of pharmacodynamic biomarkers for juvenile dermatomyositis for clinical trials R43AR073547 National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH) $225,000
Establishing a biomarker framework for feasibility studies of vamorolone in vasculitis R43AR073541 National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH) $178,041
Effectiveness of VBP15, a dissociative steroidal analogue, on chronic inflammation in a mouse model of multiple… R41AI122780 National Institute of Allergy and Infectious Diseases (NIH) $253,802

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Reveragen Biopharma, Inc. registered in SAM.gov?

Yes. Reveragen Biopharma, Inc.'s SAM.gov registration is active through December 4, 2026.

What is Reveragen Biopharma, Inc.'s most recent federal award?

Reveragen Biopharma, Inc.'s most recent federal grant award is Vamorolone trial in becker muscular dystrophy (R01FD007284), from FDA Office of Acquisition and Grant Services, on September 15, 2021.

On GovTribe

See Reveragen Biopharma, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login